Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA)

Phytomedicine

Volumn 21, Issue 7, 2014, Pages 936-941

  Zuo, G Y ^a   Han, Z Q ^a,b   Hao, X Y ^b   Han, J ^c   Li, Z S ^d   Wang, G C ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d Chengdu Military Command CDC   (China)

Author keywords

Aminoglycoside; Anti MRSA activity; Bactericidal; Brazilin; Synergy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZYLCHROMAN DERIVATIVE; BRAZILEIN; BRAZILIN; CAESALPINIA SAPPAN EXTRACT; CEFAZOLIN; CEFTAZIDIME; CHINESE DRUG; CHROMAN DERIVATIVE; ETIMICIN; GENTAMICIN; PENICILLIN DERIVATIVE; SAPPANONE B; STREPTOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BENZOPYRAN DERIVATIVE; HERBACEOUS AGENT; INDENE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; CAESALPINIA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; MICROBIAL SENSITIVITY TEST;

CAESALPINIA SAPPAN; FABACEAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BENZOPYRANS; CAESALPINIA; CHROMANS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; INDENES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE;

EID: 84901632793     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.03.004     Document Type: Article

References (33)

1. A.J. Alanis Resistance to antibiotics: are we in the post-antibiotic era? Arch. Med. Res. 36 2005 697 705
2. J. An, G.Y. Zuo, X.Y. Hao, G.C. Wang, and Z.S. Li Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) Phytomedicine 18 2011 990 993
3. J.N. Chin, R.N. Jones, H.S. Sader, P.B. Savage, and M.J. Rybak Potential synergy activity of the novel ceragenin, CAS-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa J. Antimicrob. Chemother. 61 2008 365 370
4. Clinical Laboratory Standards Institute Methods for Determining Bactericidal Activity Antimicrobial Agents. Approved Guidelines. Document M26-A 1999 CLSI (formerly NCCLS) Wayne, PA
5. Clinical Laboratory Standards Institute Performance Standards for Antimicrobial Disk Susceptibility Tests 9th ed. 2006 Approved Standard Document M2-A9, CLSI Wayne, PA
6. Clinical Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically 7th ed. 2006 Approved Standard M7-A7, CLSI Wayne, PA
7. Clinical Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing-17th Informational Supplement 2007 Approved Standard M100-S17, CLSI Wayne, PA
8. Clinical Laboratory Standards Institute Table 2C. Zone Diameter and MIC Interpretive Standards for Staphylococcus spp. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement 2012 Approved Standard M100-S22, CLSI Wayne, PA
9. D. Dubey, S. Rath, M.C. Sahu, L. Pattnaik, N.K. Debata, and R.N. Padhy Surveillance of infection status of drug resistant Staphylococcus aureus in an Indian teaching hospital Asian. Pac. J. Trop. Dis. 3 2013 133 142
10. C.D. Freeman, D.P. Nicolau, P. Paul, P.P. Belliveau, and C.H. Nightingale Once-daily dosing of aminoglycosides: review and recommendations for clinical practice J. Antimicrob. Chemother. 39 1997 677 686
11. L. Freire-Moran, B. Aronsson, C. Manz, I.C. Gyssens, A.D. So, D.L. Monnet, and O. Cars Critical shortage of new antibiotics in development against multidrug-resistant bacteria - time to react is now Drug Resist. Updat. 14 2011 118 124
12. S. Gibbons Anti-staphylococcal plant natural products Nat. Prod. Rep. 21 2004 263 277
13. S. Gibbons Phytochemicals for bacterial resistance - strengths, weaknesses and opportunities Planta Med. 74 2008 594 602
14. S. Hemaiswarya, A.K. Kruthiventi, and M. Doble Synergism between natural products and antibiotics against infectious diseases Phytomedicine 15 2008 639 652
15. Z.Q. Hu, W.H. Zhao, N. Asano, Y. Yoda, Y. Hara, and T. Shimamura Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin resistant Staphylococcus aureus Antimicrob. Agents Chemother. 46 2002 558 560
16. M.P. Jevons Celbenin-resistant staphylococci Br. Med. J. 124 1961 124 125
17. C.T. Kåhrström Entering a post-antibiotic era? Nat. Rev. Microbiol. 11 2013 146
18. D.S. Kim, N. Baek, S.R. Oh, K.Y. Jung, I.S. Lee, and H. Lee NMR assignment of Brazilin Phytochemistry 46 1997 177 178
19. K.J. Kim, H.H. Yu, S.I. Jeong, J.D. Cha, S.M. Kim, and Y.O. You Inhibitory effects of Caesalpinia sappanon on growth and invasion of methicillin-resistant Staphylococcus aureus J. Ethnopharmacol. 91 2004 81 87
20. G.B. Mahady Medicinal plants for the prevention and treatment of bacterial infections Curr. Pharm. Des. 11 2005 2405 2427
21. Nanjing University of Traditional Chinese Medicine (NUTCM) Dictionary of Chinese Crude Drugs 2nd ed. 2005 Shanghai Scientific Technologic Publisher 1506 1508
22. H. Nikaido Multidrug resistance in bacteria Annu. Rev. Biochem. 78 2009 119 146
23. G. Orhan, A. Bayram, Y. Zer, and I. Balci Synergy tests by E test and chequerboard methods of antimicrobial combinations against Brucella melitensis J. Clin. Microbiol. 43 2005 140 143
24. N.S. Radulovic, P.D. Blagojevic, Z.Z. Stojanovic-Radic, and N.M. Stojanovic Antimicrobial plant metabolites: structural diversity and mechanism of action Curr. Med. Chem. 20 2013 932 952
25. T. Saitoh, S. Sakashita, H. Nakata, T. Shimokawa, J.E. Kinjo, J. Yamahara, M. Yamasaki, and T. Nohara 3-Benzylchroman derivatives related to brazilin from Sappan Lignum Chem. Pharm. Bull. 34 1986 2506 2511
26. S. Stefani, D.R. Chung, J.A. Lindsay, A.W. Friedrich, A.M. Kearns, H. Westh, and F.M. MacKenzie Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods Int. J. Antimicrob. Agents 39 2012 273 282
27. H. Wagner, and G. Ulrich-Merzenich Synergy research: approaching a new generation of phytopharmaceuticals Phytomedicine 16 2009 97 110
28. H.X. Xu, and S.F. Lee The antibacterial principle of Caesalpina sappan Phytother. Res. 8 2004 647 651
29. M. Zahin, F. Aqil, M.S.A. Khan, and I. Ahmad Ethnomedicinal plants derived antibacterials and their prospects Ethnomedicine: A Source of Complementary Therapeutics 2010 Research Signapost India 149 178
30. G.Y. Zuo, Y. Li, T. Wang, J. Han, G.C. Wang, Y.L. Zhang, and W.D. Pan Synergistic antibacterial and antibiotic effects of bisbenzylisoquinoline alkaloids on clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) Molecules 16 2011 9819 9826
31. G.Y. Zuo, J. An, J. Han, Y.L. Zhang, G.C. Wang, X.Y. Hao, and Z.Q. Bian Isojacareubin from the Chinese herb Hypericum japonicum with antibacterial and antibiotic synergy effects on clinical methicillin-resistant Staphylococcus aureus (MRSA) Int. J. Mol. Sci. 13 2012 8210 8218
32. G.Y. Zuo, F.Y. Meng, X.Y. Hao, Y.L. Zhang, G.C. Wang, and G.L. Xu Antibacterial Alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus J. Pharm. Pharm. Sci. 11 2008 90 94
33. G.Y. Zuo, G.C. Wang, Y.B. Zhao, G.L. Xu, X.Y. Hao, J. Han, and Q. Zhao Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) J. Ethnopharmacol. 120 2008 287 290